MedTrace Logo

Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections

NCT04357938 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2021-09-20

No results posted yet for this study

Summary

The study objective is to investigate the diagnostic value and consistency of chest CT as compared with comparison to RT-PCR assay in COVID-19 in patients which were stratified for hospital admission.

Conditions

  • Severe Acute Respiratory Syndrome Coronavirus 2

Interventions

DEVICE

CT-imaging

Chest CT to rule out pneumonia in PCR negative, nonspecific symptomatic patients to prevent the spread of SARS-CoV-2 within the hospital.

Sponsors & Collaborators

  • Jena University Hospital

    lead OTHER

Principal Investigators

  • Ulf Teichgräber, Prof. Dr. · Department of Radiology, Jena University Hospital, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2020-05-20
Completion
2020-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04357938 on ClinicalTrials.gov